Insiders / Reardon Andrew / Activity
Activity — Reardon Andrew
22 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 14, 2026 | Other | LGND Ligand Pharmaceuticals Inc Common Stock | $750.6K | -4K -9.42% | 39,255 0.20% of shares | low |
| Feb 14, 2026 | Other | LGND Ligand Pharmaceuticals Inc Common Stock | $590.3K | -3K -8.51% | 34,528 0.17% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $300.9K | -1K -3.66% | 38,011 0.19% of shares | medium |
| Mar 4, 2026 | Exercise | LGND Ligand Pharmaceuticals Inc Common Stock | $261.4K | +5K +13.56% | 41,869 0.21% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $238.5K | -1K -3.00% | 36,869 0.18% of shares | medium |
| Feb 15, 2026 | Other | LGND Ligand Pharmaceuticals Inc Common Stock | $182.4K | -992 -2.62% | 36,869 0.18% of shares | low |
| Feb 15, 2026 | Other | LGND Ligand Pharmaceuticals Inc Common Stock | $147.2K | -801 -2.07% | 37,861 0.19% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $126.7K | -612 -1.53% | 39,457 0.20% of shares | medium |
| Feb 15, 2026 | Other | LGND Ligand Pharmaceuticals Inc Common Stock | $109.0K | -593 -1.51% | 38,662 0.19% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $94.4K | -460 -1.13% | 40,409 0.20% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $70.2K | -340 -0.84% | 40,069 0.20% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $60.5K | -300 -0.73% | 41,069 0.21% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $41.4K | -207 -0.50% | 41,462 0.21% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $40.8K | -200 -0.49% | 40,869 0.21% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $19.9K | -100 -0.24% | 41,669 0.21% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $19.8K | -100 -0.24% | 41,769 0.21% of shares | low |
| Mar 4, 2026 | Sell | LGND Ligand Pharmaceuticals Inc Common Stock | $18.7K | -93 -0.22% | 41,369 0.21% of shares | low |
| Feb 14, 2026 | Grant | LGND Ligand Pharmaceuticals Inc Common Stock | $0 | +9K +25.52% | 43,338 0.22% of shares | low |
| Feb 14, 2026 | Grant | LGND Ligand Pharmaceuticals Inc Common Stock | $0 | +7K +22.49% | 37,739 0.19% of shares | low |
| Mar 2, 2026 | Grant | LGND Ligand Pharmaceuticals Inc Common Stock | $0 | +5K +12.24% | 41,382 0.21% of shares | low |
| Mar 4, 2026 | Exercise | LGND Ligand Pharmaceuticals Inc Employee Stock Option (right to buy) | — | -5K -8.41% | 54,444 0.27% of shares | low |
| Mar 2, 2026 | Grant | LGND Ligand Pharmaceuticals Inc Employee Stock Option (right to buy) | — | +22K | 21,525 0.11% of shares | low |